Skip to content

Opening book details…

About this Medicine article

Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial by Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E.
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E.

Browse all works by Parker, Christopher; Zhan, Lin; Cislo, Paul; Reuning-Scherer, Jonathan; Vogelzang, Nicholas J.; Nilsson, Sten; Sartor, Oliver; O'Sullivan, Joe M.; Coleman, Robert E.